Granowitz Craig B 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Granowitz Craig B
SVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-28+35,790→ 111,333 total - Exercise/Conversion
Common Stock
2025-02-28+74,227→ 185,560 total - Tax Payment
Common Stock
2025-02-28$0.67/sh−65,308$43,756→ 120,252 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−74,227→ 148,453 total→ Common Stock (74,227 underlying) - Exercise/Conversion
Common Stock
2025-02-28+27,917→ 75,543 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−27,917→ 0 total→ Common Stock (27,917 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-28−35,790→ 35,790 total→ Common Stock (35,790 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.